Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Moiola

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 27, 2021
Fingolimod as an effective therapeutic strategy for pediatric relapsing-remitting multiple sclerosis: two case reportsChiara Zanetta, Massimo Filippi, Lucia Moiola
Expert Review of Neurotherapeutics|October 12, 2020
Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?Giancarlo Comi, Gloria Dalla Costa, Lucia Moiola
Current Opinion in Neurology|May 7, 2020
Prevention and management of adverse effects of disease modifying treatments in multiple sclerosisLucia Moiola, Paulus S Rommer, Uwe K Zettl
AJNR. American Journal of Neuroradiology|February 20, 2003
Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy studyAnna Gambini, Andrea Falini, Lucia Moiola, et al.
Expert Review of Neurotherapeutics|November 7, 2022
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?Maria Sofia Martire, Lucia Moiola, Maria Assunta Rocca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 13, 2020
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosisPaolo Preziosa, Elisabetta Pagani, Lucia Moiola, et al.
Human Brain Mapping|December 25, 2008
Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients?Maria A Rocca, Martina Absinta, Angelo Ghezzi, et al.
Journal of Neurology|September 19, 2024
Monoaminergic network abnormalities are associated with fatigue in pediatric multiple sclerosisMonica Margoni, Paola Valsasina, Lucia Moiola, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2014
Recurrence of disease activity after repeated Natalizumab withdrawalsLaura Ferrè, Lucia Moiola, Francesca Sangalli, et al.
Current Neuropharmacology|December 20, 2021
Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine TabletsLucia Moiola, Agostino Riva, Ferdinando Nicoletti, et al.
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 27, 2021
Fingolimod as an effective therapeutic strategy for pediatric relapsing-remitting multiple sclerosis: two case reportsChiara Zanetta, Massimo Filippi, Lucia Moiola
Expert Review of Neurotherapeutics|October 12, 2020
Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?Giancarlo Comi, Gloria Dalla Costa, Lucia Moiola
Current Opinion in Neurology|May 7, 2020
Prevention and management of adverse effects of disease modifying treatments in multiple sclerosisLucia Moiola, Paulus S Rommer, Uwe K Zettl
AJNR. American Journal of Neuroradiology|February 20, 2003
Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy studyAnna Gambini, Andrea Falini, Lucia Moiola, et al.
Expert Review of Neurotherapeutics|November 7, 2022
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?Maria Sofia Martire, Lucia Moiola, Maria Assunta Rocca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 13, 2020
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosisPaolo Preziosa, Elisabetta Pagani, Lucia Moiola, et al.
Human Brain Mapping|December 25, 2008
Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients?Maria A Rocca, Martina Absinta, Angelo Ghezzi, et al.
Journal of Neurology|September 19, 2024
Monoaminergic network abnormalities are associated with fatigue in pediatric multiple sclerosisMonica Margoni, Paola Valsasina, Lucia Moiola, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2014
Recurrence of disease activity after repeated Natalizumab withdrawalsLaura Ferrè, Lucia Moiola, Francesca Sangalli, et al.
Current Neuropharmacology|December 20, 2021
Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine TabletsLucia Moiola, Agostino Riva, Ferdinando Nicoletti, et al.
Pageof 16